网站主页 >> CAS数据库列表 >> (GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
(GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
|
|
|
- CAS号:
- 909115-33-9
- 英文名:
- FMOC-GLU(OTBU)-SER(PSI-ME,MEPRO)-OH
- 英文别名:
- Fmoc-Glu-Ser(ΨMe,MePro)-OH;Fmoc-Glu(OtBu)-Ser[Ψ(Me,Me)Pro]-OH;Fmoc-Glu(tBu)-Ser[PSI(Me,Me)Pro]-OH;FMOC-GLU(OTBU)-SER(PSI-ME,MEPRO)-OH;FMOC-GLU(OOtbu)-SER(PSI-ME,MEPRO)-OH;Fmoc-L-Glu(tBu)-L-Ser[PSI(Me,Me)Pro]-OH;Fmoc-L-Glu(otBu)-L-Ser[PSI(Me,Me)Pro]-OH;FMOC-GLU(OTBU)-SER(ΨME,ME PRO)-OH_909115-33-9;Fmoc-Glu(OtBu)-Ser[Psi(Me,Me)Pro]-OH≥ 99% (HPLC);(9H-Fluoren-9-yl)MethOxy]Carbonyl Glu(OtBu)-SerPsi(Me,Me)Pro-OH
- 中文名:
- (GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
- 中文别名:
- (GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯;(S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-5-(叔丁氧基)-5-氧代戊酰基)-2,2-二甲基恶唑烷-4-羧酸
- CBNumber:
- CB0313470
- 分子式:
- C30H36N2O8
- 分子量:
- 552.62
- MOL File:
- Mol file
|
|
|
(GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯化学性质
-
沸点:
-
759.9±60.0 °C(Predicted)
-
|
-
密度:
-
1.250±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at +2°C to +8°C.
-
|
-
酸度系数(pKa):
-
3.08±0.40(Predicted)
-
|
(GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯性质、用途与生产工艺
(GAMMAS，4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2，2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯可用于固相制备促胰液素，胰液素(英文名Secretin)是由位于十二指肠和空肠上段粘膜中的S细胞分泌，由27个氨基酸组成的具有螺旋结构的碱性多肽，具有调节胰腺外分泌、抑制胃酸分泌和胃运动等多种生理功能。
Fmoc-Glu(OtBu)-Ser(psi(Me,Me)pro)-OH 是一种二肽。
(GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
上下游产品信息
上游原料
下游产品
(GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
生产厂家
909115-33-9, (GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯 相关搜索:
(4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸 (5R)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸 (5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S)-3-[(2S,3S)-2-[[芴甲氧羰基]氨基]-3-甲基-1-氧代戊基]-2,2-二甲基-4-恶唑烷羧酸 FMOC-GLY-THR(PSIME,MEPRO)-OH (4S,5R)-3-(N-芴甲氧羰基丙氨酰)-2,2,5-三甲基恶唑烷-4-羧酸 (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯 (4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2-二甲基-4-恶唑烷羧酸 (5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2,5-三甲基-4-恶唑烷羧酸 (4S)-3-[2-[[芴甲氧羰基]氨基]乙酰基]-2,2-二甲基-4-恶唑烷羧酸 (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2,5-三甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯 (4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,5-二氧代-5-[(三苯基甲基)氨基]戊基]-2,2,5-三甲基-4-恶唑烷羧酸
- peptide
- 化工试剂
- 伪二肽
- 假二肽
- (S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-5-(叔丁氧基)-5-氧代戊酰基)-2,2-二甲基恶唑烷-4-羧酸
- (GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
- 909115-33-9
- FMOC-GLU(OOtbu)-SER(PSI-ME,MEPRO)-OH
- (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid
- Fmoc-Glu-Ser(ΨMe,MePro)-OH
- 3-Oxazolidinepentanoic acid, 4-carboxy-γ-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,2-dimethyl-δ-oxo-, 3-(1,1-dimethylethyl) ester, (γS,4S)-
- Fmoc-L-Glu(otBu)-L-Ser[PSI(Me,Me)Pro]-OH
- FMOC-GLU(OTBU)-SER(ΨME,ME PRO)-OH_909115-33-9
- (4S)-3-[(2S)-5-(tert-butoxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxopentanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
- Fmoc-Glu(tBu)-Ser[PSI(Me,Me)Pro]-OH
- (4S)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
- (9H-Fluoren-9-yl)MethOxy]Carbonyl Glu(OtBu)-SerPsi(Me,Me)Pro-OH
- Fmoc-L-Glu(tBu)-L-Ser[PSI(Me,Me)Pro]-OH
- Fmoc-Glu(OtBu)-Ser[Ψ(Me,Me)Pro]-OH
- Fmoc-Glu(OtBu)-Ser[Psi(Me,Me)Pro]-OH≥ 99% (HPLC)
- (S)-3-[Nα-(9-Fluorenylmethyloxycarbonyl)-L-glutamyl-tert-butyl ester]-2,2-dimethyloxazolidine-4-carboxylic acid
- (gammaS,4S)-4-Carboxy-gamma-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2,2-dimethyl-delta-oxo-3-oxazolidinepentanoic acid 3-(1,1-dimethylethyl) ester
- FMOC-GLU(OTBU)-SER(PSI-ME,MEPRO)-OH